Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

This seemingly unrelated health issue could have a serious impact on a person's future risk of developing dementia ...

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...

Over 150 million people will be living with dementia by 2050, estimates suggest--more than double the number today.

Now, scientists say that eating just a couple of eggs a week could significantly reduce Alzheimer’s risk in older adults.

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is so confusing. I have early Alzheimer’s and have trouble organizing my ...

WHY do some people develop dementia, while others don’t? It’s a question that’s baffled scientists for decades. Some blame ...

The second theory, which is newer, suggests that Alzheimer’s may be caused by problems with how cells in the brain produce ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

A new study from the University of Oxford has identified a "critical time window" in which certain illnesses increase the risk of dementia.

Scientists have used AI to re-analyse a clinical trial for an Alzheimer's medicine, and identified a group of patients who responded to treatment. The ...